AA38-3

CAS No. 65815-76-1

AA38-3( 1-Piperidinecarboxylic acid, 4-nitrophenyl ester )

Catalog No. M28641 CAS No. 65815-76-1

AA38-3 inhibites three SHs (ABHD6, ABHD11, and FAAH).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 36 In Stock
25MG 73 In Stock
50MG 124 In Stock
100MG 221 In Stock
200MG 325 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AA38-3
  • Note
    Research use only, not for human use.
  • Brief Description
    AA38-3 inhibites three SHs (ABHD6, ABHD11, and FAAH).
  • Description
    AA38-3 inhibites three SHs (ABHD6, ABHD11, and FAAH).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-Piperidinecarboxylic acid, 4-nitrophenyl ester
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FAAH
  • Recptor
    calmodulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65815-76-1
  • Formula Weight
    250.25
  • Molecular Formula
    C12H14N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (199.80 mM)
  • SMILES
    [O-][N+](c(cc1)ccc1OC(N1CCCCC1)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.AN Wali, et al. Effect of three calmodulin antagonists on subpopulations of CD44/CD24 immunophenotypes in breast cancer cell lines. Tropical Journal of Pharmaceutical Research. 2015 Sep; 14(8).
molnova catalog
related products
  • Palmitoylisopropylam...

    Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low concentrations.

  • N-Benzyllinolenamide

    N-Benzyllinolenamide is a natural product. It is an inhibitor of fatty acid amide hydrolase (FAAH, IC50 of 41.8 μM).

  • URB-597

    A potent and selective FAAH inhibitor with IC50 of 4.6 nM; increases anandamide levels in the brain of rats and wild-type mice (0.3 mg/kg i.p.); improves cognitive impairment by inhibiting mTOR-dependent autophagy in a CCH model.